Trial Information

Summary: A Study of NT-Pro Brain Natriuretic Peptide (NT-proBNP) in Patients Presenting With Acute Dyspnea.

Status: Completed

Protocol Number: CAN0010

Sponsor:

Company Division: Diagnostic

Official Scientific Title: The 'improved management of patients with congestive heart failure in Canada (IMPROVE-CHF CANADA)' study.

Brief Summary: This study will evaluate the use of plasma NT-proBNP measurements to improve the diagnostic accuracy of congestive heart failure (CHF) and the prediction of clinical outcomes in patients who present to emergency departments with acute dyspnea. Patients will be randomized to a conventional care group, or to conventional care plus measurement of plasma NT-proBNP.

Study Phase: N/A

Study Design / Study Details:

• Purpose:
• Allocation: Randomized
• Masking: Double Blind
• Control:
• Assignment: Parallel
• Endpoints:

Study Type:

Condition: Congestive Heart Failure

Intervention Type: Diagnostic Test

Intervention Name: ELECSYS®proBNP

Primary Outcome:

Key Secondary Outcomes:

Inclusion Criteria:

Exclusion Criteria:

Gender: Males or Females

Age Limits: Min: 18 Years

Accepts Healthy Volunteers: No

Anticipated Start Date: December, 2004

Trial Registration Date: 11/23/2006

Date Last Updated: 12/08/2006

Link To Trial Results

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: September 2, 2008 at 1:51:09 PM